These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2513950)

  • 41. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Shehab N; DePestel DD; Mackler ER; Collins CD; Welch K; Erba HP
    Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergy. Should it determine antibiotic selection in neutropenic patients?
    Bodey GP
    Arch Intern Med; 1985 Nov; 145(11):1964-6. PubMed ID: 4062443
    [No Abstract]   [Full Text] [Related]  

  • 43. Amphotericin B treatment of fungemia due to unusual pathogens in neutropenic patients: report of two cases.
    Fanci R; Pecile P; Martinez RL; Fabbri A; Nicoletti P
    J Chemother; 1997 Dec; 9(6):427-30. PubMed ID: 9491843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
    Fainstein V; Bodey GP; Bolivar R; Elting L; McCredie KB; Keating MJ
    Arch Intern Med; 1984 Sep; 144(9):1766-70. PubMed ID: 6383246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of severe febrile neutropenia (author's transl)].
    Meuret G; Roux A; Heim ME; Westerhausen M
    Dtsch Med Wochenschr; 1980 Dec; 105(51):1776-9. PubMed ID: 6449360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of long term lithium therapy on red blood cell choline transport in neutropenic patients.
    Falezza G; Corrocher R; Olivieri O; Gandini G; Bonetti A; Bassetto MA; De Sandre G
    Haematologica; 1985; 70(3):202-4. PubMed ID: 3932147
    [No Abstract]   [Full Text] [Related]  

  • 47. Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient.
    Parr MD; Waite WW; Hansen LA; McDaniel PA
    Am J Hosp Pharm; 1985 Nov; 42(11):2484-8. PubMed ID: 4073066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
    Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S
    N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of fluconazole prophylaxis on fever and use of amphotericin in neutropenic cancer patients. Bone Marrow Transplantation Team.
    Chandrasekar PH; Gatny CM
    Chemotherapy; 1994; 40(2):136-43. PubMed ID: 8131635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amphotericin B colloidal dispersion versus amphotericin B in the empirical treatment of fever and neutropenia.
    Roland WE
    Clin Infect Dis; 1999 Apr; 28(4):935-6. PubMed ID: 10825081
    [No Abstract]   [Full Text] [Related]  

  • 51. Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
    Manzoor NF; Azim S; Fadoo Z
    J Pak Med Assoc; 2010 Nov; 60(11):977-9. PubMed ID: 21375212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia.
    Pascual B; Ayestaran A; Montoro JB; Oliveras J; Estibalez A; Julia A; Lopez A
    Ann Pharmacother; 1995 Dec; 29(12):1197-201. PubMed ID: 8672820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
    Pagano L; Valentini CG; Fianchi L; Caira M
    J Chemother; 2011 Feb; 23(1):5-8. PubMed ID: 21482486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of the critical path with the electronic chart system using meropenem, vancomycin, liposome amphotericin B for the febrile neutropenia].
    Komatsu T; Kimura Y; Sudo M
    Jpn J Antibiot; 2011 Jun; 64(3):191-9. PubMed ID: 21861310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia.
    Johansen HK; Gotzsche PC
    Cochrane Database Syst Rev; 2000; (3):CD000969. PubMed ID: 10908480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antimicrobial therapy of neutropenia].
    Harten P; Euler HH
    Dtsch Med Wochenschr; 1998 Jan; 123(4):100-1. PubMed ID: 9487293
    [No Abstract]   [Full Text] [Related]  

  • 57. Vancomycin-induced neutropenia.
    Strikas R; Studlo J; Venezio FR; O'Keefe JP
    J Infect Dis; 1982 Oct; 146(4):575. PubMed ID: 7119483
    [No Abstract]   [Full Text] [Related]  

  • 58. Lithium therapy in congenital neutropenia.
    Barrett AJ; Griscelli C; Buriot D; Faille A
    Lancet; 1977 Dec 24-31; 2(8052-8053):1357-8. PubMed ID: 74762
    [No Abstract]   [Full Text] [Related]  

  • 59. Cyclosporin A in adult-onset cyclic neutropenia.
    Selleri C; Catalano L; Alfinito F; De Rosa G; Vaglio S; Rotoli B
    Br J Haematol; 1988 Jan; 68(1):137-8. PubMed ID: 3345290
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of idiopathic chronic neutropenia with high-dose intravenous immunoglobulin.
    Lakos A; Timár L
    Am J Dis Child; 1987 Jan; 141(1):12-3. PubMed ID: 3788874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.